All Articles

A massive reinsurance deal isn't just about money; it's about strategy. Unum is shedding risky policies, and Fortitude Re is pioneering a new risk model.

A new academy is offering Hong Kong professionals a complex but lucrative path to dual legal practice. Is this the key to unlocking the Greater Bay Area?

A US med-tech firm just invested in a German airline. The goal: to build a private air network for organs and revolutionize a broken transplant system.

Exceptional new drill results confirm a richer, deeper PGM deposit, while a strategic pivot into copper-gold exploration reveals a larger vision for Bravo.

In a savvy move, Coast Copper divests a gold asset to Talisker, showcasing a capital strategy that could serve as a model for the junior mining sector.

Phoebe Greenberg's two-decade mission culminates in a new Montréal institution, blending heritage with innovation through a powerful public-private partnership.

Australian biotech Immuron hires a top dealmaker to land a partner for its novel C. diff therapy. The goal: secure funding and unlock a potential $400M market.

Englobe's acquisition of Pluritec isn't just a merger; it's a calculated move to dominate Québec's booming infrastructure market. Here's how.

Buoyed by stellar well results, Logan Energy is boosting its 2026 spending and output targets, a confident bet on its Montney assets amid market uncertainty.

With its AUM soaring to $600B, Mubadala Capital is making a bold play in private credit, signaling a new era for sovereign-backed asset managers.

After a Health Canada-mandated pause, LSL's Steri-Med is near full remediation. This is more than a fix—it’s a calculated play for North American market leadership.

After facing collapse, an 80-year-old grape giant is saved by its lender. The deal reveals a new survival model for America's legacy farms.

Saints & Masters' acquisition of Xencia targets ₹1,000-crore revenue, creating 1,000+ jobs and escalating its multi-cloud AI strategy in India.

Just two years old, UK fertility startup Avenues is expanding globally with an AI-driven model promising unprecedented growth. But can tech truly scale compassion?

Ryan Specialty’s new consortium with six Lloyd’s syndicates isn't just a capacity play. It’s a tech-driven model for the future of delegated underwriting.

Emirates NBD's new partnership with Techstars isn't just another accelerator; it's a strategic move to directly integrate AI startups into its core operations.

A new partnership promises to give our aging power grids a high-resolution nervous system, tackling the immense pressures of AI, EVs, and renewables.

While UK consulting exports soar, a closer look at the data reveals a story of domestic slowdowns, a shifting workforce, and an urgent push for new skills.

With the appointment of a veteran CTO, amana signals its ambition not just to compete but to define the next era of digital investing in the Middle East.

UK biotech Ananda Pharma advances its MRX1 drug to Phase 2 trials, targeting a debilitating chemotherapy side effect with no current effective treatment.